Hoth Therapeutics
Stock Forecast, Prediction & Price Target
Hoth Therapeutics Financial Estimates
Hoth Therapeutics Revenue Estimates
Hoth Therapeutics EBITDA Estimates
Hoth Therapeutics Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $177.52M Low: $177.52M High: $177.52M avg. 0% | Avg: $0 Low: $0 High: $0 avg. -100% | ||
Net Income
% change YoY
| $-14.31M N/A | $-11.67M 18.41% | $-7.84M 32.81% | Avg: $-16M Low: $-3.88M High: $-3.88M avg. -103.94% | Avg: $0 Low: $0 High: $0 avg. 100% | ||
EBITDA
% change YoY
| $-14.10M N/A | $-10.67M 24.27% | $-153.14K 98.56% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | ||
EPS
% change YoY
| -$16.03 N/A | -$9.75 39.17% | -$2.3 76.41% | Avg: -$1.14 Low: -$1.14 High: -$1.14 avg. 50.43% | Avg: $0 Low: $0 High: $0 avg. 100% | ||
Operating Expenses
% change YoY
| $14.10M N/A | $11.06M -21.52% | $7.69M -30.48% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Hoth Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -51.97% in 2025-2026.
We have gathered data from 1 analysts. Their low estimate is -3.88M, average is -16M and high is -3.88M.
What is Hoth Therapeutics stock revenue growth forecast?
We have gathered data from 1 analysts. Their low revenue estimate is $177.52M, average is $177.52M and high is $177.52M.
What is Hoth Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 25.21% in 2025-2026.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$1.14, average is -$1.14 and high is $-1.14.